Skip to main content
. 2017 Apr 26;2017(4):CD010770. doi: 10.1002/14651858.CD010770.pub2

NCT02357563.

Trial name or title Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
Methods Randomised controlled trial
Participants Premenopausal women with G2 submucosal leiomyoma < 3 cm, symptoms of menometrorrhagia, menstrual disorder, infertility, pelvic pain
Interventions Ulipristal acetate 5 mg/d for 2 courses of 3 months each vs IM on leuprolide acetate 11.25 in luteal phase repeated 3 months later
Outcomes Proportion of restored uterine cavity 1 year after enrolment
Starting date February 2015
Contact information Fulvio Zullo, University Magna Graecia
Notes